Syndivia

Syndivia is a biotechnology company that is developing a pipeline of targeted therapies for solid cancers by leveraging a specific targeting of the tumor microenvironment and anatomical hallmarks of solid tumors. Syndivia's mission is to develop new therapies for patients with the most difficult-to-treat cancer indications.